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Differential gene expression following early renal ischemia/ Ischemia/reperfusion injury is a leading cause of acute
reperfusion. renal failure, a common clinical condition still associated
Background. Acute renal failure from ischemia/reperfusion with high mortality and morbidity despite significant ad-injury is associated with tubule cell apoptosis, the molecular
vances in supportive care [1]. Important advances havemechanisms of which remain under active investigation. The
recently been made in defining the cell biologic conse-purpose of this study was to identify apoptosis-related genes
that are differentially expressed in the early periods following quences of ischemic renal injury [2, 3]. The morphologic
renal ischemia. response of renal tubular cells depends on the intensity
Methods. Mice underwent unilateral renal artery clamping
and severity of ischemia and includes loss of cell polarity,for 45 minutes and were sacrificed at 0, 3, 12, or 24 hours
cell death, dedifferentiation of viable cells, proliferation,of reperfusion. Tubule cell apoptosis was confirmed by DNA
laddering and terminal deoxynucleotidyl transferase-mediated differentiation, and restitution of a normal epithelium
uridine triphosphate nick end labeling (TUNEL) assay. We [2, 3]. The molecular mechanisms underlying each of
employed cDNA microarrays to define global changes in renal these phenomena are under active investigation and holdgene expression. Semiquantitative reverse transcription-poly-
significant promise for novel therapeutic interventionsmerase chain reaction (RT-PCR) and immunohistochemistry
aimed at ameliorating cell death and/or accelerating thewere used as confirmatory tools.
Results. By microarray analysis, we identified consistent pat- recovery process.
terns of altered gene expression, including transcription factors, Apoptosis has recently emerged as a potential mecha-
growth factors, signal transduction molecules, and apoptotic
nism leading to tubular cell death following ischemicfactors. Prominent among the last category included FADD,
injury [4, 5]. Apoptosis, characterized by cell shrinkage,DAXX, BAD, BAK, and p53. Up-regulation of these proapo-
ptotic genes was confirmed by semiquantitative RT-PCR and nuclear condensation, and internucleosomal DNA frag-
immunohistochemistry. mentation, has been documented in cultured tubule cells
Conclusion. The results indicate that apoptosis may repre- following adenosine triphosphate (ATP) depletion [6–9],sent an important mechanism for the early loss of tubule cells
in mouse and rat models of ischemic renal injury [10–16],following ischemia/reperfusion injury. Both the death receptor-
and in human biopsy samples from transplanted cadav-dependent (FADD-DAXX) and mitochondrial (BAD-BAK)
pathways are activated. The results also provide a molecular eric kidneys [17, 18]. Considerable interest has therefore
basis for the previous findings that significant intrarenal mecha- been directed toward identification of the intracellular
nisms exist to enable tubule cell repair and regeneration, as
pathways involved in the stimulus recognition, signalevidenced by the up-regulation of genes such as growth, prolif-
transduction, and execution phases of tubular cell apo-eration, transcription, and cytoskeletal factors.
ptosis following ischemia/reperfusion injury.
In recent years, specific proteases belonging to the
caspase family have surfaced as crucial effectors of apo-
ptosis [19]. Members of this family are expressed as pro-
enzymes and require activation by upstream stimuli inKey words: apoptosis, acute renal failure, ischemia, microarray,
RT-PCR. order to commit a cell into the execution phase of apo-
ptosis. The major intracellular apoptotic pathways may
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Fas (the “extrinsic” pathway) and its signal-transducing emia, including the presence of apoptotic tubular epithe-
lial cells, have been extensively documented [10–12].ligands such as FADD and DAXX [20]. On the other
hand, activation of the initiator pro-caspase 9 is depen- Briefly, male Swiss-Webster mice (Taconic Farms, Ger-
mantown, NY, USA) weighing 25 to 35 g were houseddent primarily on “intrinsic” mitochondrial signaling
pathways regulated by members of the Bcl-2 family [21]. with 12-hour light and 12-hour dark cycle and were al-
lowed free access to food and water. The animals wereActivation of proapoptotic Bcl-2 family members such as
BAD and BAK can trigger a sequence of events leading anesthetized with sodium pentobarbital (50 mg/kg intra-
peritoneally), and placed on a warming table to maintainto release of mitochondrial cytochrome c into the cytosol,
and activation of pro-caspase 9 [22]. Once activated, both a rectal temperature of 37C. The left kidney was ex-
posed by a flank incision. The left renal pedicle wascaspases 8 and 9 participate in a cascade that culminates
in the activation of caspase 3, which cleaves several sub- occluded with a nontraumatic vascular clamp for 45 min-
utes, during which time the kidney was kept warm andstrates resulting in chromosomal DNA fragmentation and
cellular morphologic changes characteristic of apoptosis moist. The clamp was then removed, the kidney observed
for return of blood flow, and the incision sutured. The[19]. The p53 protein is a potent regulator of apoptosis,
most notably by activating proapoptotic Bcl-2 family mice were allowed to recover in a warmed cage. After
0, 3, 12, or 24 hours of reperfusion, the mice were sacri-members as well as the Fas-FADD axis [23]. The anti-
apoptotic Bcl-2 family members such as Bcl-2 itself play ficed with intraperitoneal pentobarbital, and both kid-
neys harvested (the right kidney served as a control fora pivotal protective role by preserving mitochondrial
structure and inhibiting cytochrome c release [21]. each animal). Three separate animals were examined at
each reflow period. The kidneys were snap-frozen inAttempts at unraveling the molecular basis of these
myriad apoptotic mechanisms, as well as the many other liquid nitrogen and stored at 70C until further pro-
cessing; a sample was fixed in formalin, paraffin-embed-renal responses to ischemic injury, have been signifi-
cantly facilitated by recent advances in functional geno- ded, and sectioned (4 m). Sections were stained with
hematoxylin and eosin and examined histologically formics that have yielded new tools for genome-wide analy-
sis of complex biologic processes [24, 25]. The DNA the characteristic morphologic changes resulting from
ischemia/reperfusion injury, or processed for terminalmicroarray methodologies provide parallel and quantita-
tive expression profiles of thousands of genes, which, deoxynucleotidyl transferase-mediated uridine triphos-
phate nick end labeling (TUNEL) assay as detailed below.when combined with bioinformatics, can identify genes
in a biologic pathway, characterize the function of novel
Apoptosis assaysgenes, analyze genetic variation, detect disease sub-
Internucleosomal DNA fragmentation was detectedclasses, and identify drug targets [24–29]. The purpose
in situ utilizing the terminal deoxynucleotidyl transferaseof this study was to utilize cDNA microarrays to define
(TdT)-mediated uridine triphosphate (dUTP) nick endglobal changes in renal gene expression during the early
labeling (TUNEL) assay (ApoAlert DNA Fragmenta-reperfusion periods following ischemic injury in a mouse
tion Assay Kit, Clontech, La Jolla, CA, USA). Paraffinmodel and specifically to identify genes that may mediate
sections were deparaffinized through zylene and de-apoptosis following an ischemic insult. We identified sev-
scending grades of ethanol, fixed with 4% formaldehyde/eral genes that were consistently up-regulated at early
phosphate-buffered saline (PBS) for 30 minutes at 4C,reperfusion periods, including transcription factors,
permeabilized with proteinase K at room temperaturegrowth factors, signal transduction molecules, cytoskele-
for 15 minutes and 0.2% triton X-100/PBS for 15 minutestal elements, and apoptotic factors. Prominent among
at 4C, and incubated with a mixture of nucleotides andthe last category included FADD, DAXX, BAD, BAK,
TdT enzyme for 60 minutes at 37C. The reaction wasand p53. Up-regulation of these proapoptotic genes was
terminated with 2 standard sodium citrate (SSC), theconfirmed by reverse transcription-polymerase chain re-
sections washed with PBS, and mounted with crystal/action (RT-PCR) and immunohistochemistry. The re-
mount (Biomeda, Foster City, CA, USA). Fluorescentsults suggest that apoptosis may represent an important
nuclei were detected by visualization with a microscopemechanism for the early loss of tubule cells following
equipped with fluorescein filters (IX70, Olympus, Lakeischemia-reperfusion injury, and identify possible molec-
Success, NY, USA). As a negative control, sections wereular mechanisms that may be responsible for tubule cell
incubated in the absence of TdT enzyme. The degreerepair and regeneration.
of apoptosis was estimated by counting the number of
TUNEL-positive cells per 100 tubular epithelial cellsMETHODS
examined, since apoptosis was restricted predominantly
Renal ischemia/reperfusion injury model to this cell type.
The presence of apoptosis was confirmed by DNA lad-We utilized a well-established murine model of renal
ischemia/reperfusion injury, in which the structural and dering assay. Briefly, equal amounts of frozen whole kidney
tissue were disrupted with a Tissue Tearor (Biospec Prod-functional consequences of brief periods of renal isch-
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ucts, Racine, WI, USA), resuspended in 500 L of lysis Cy3 and Cy5 channels and equalizing them. The correla-
tion coefficiency of log of normalized ratios for all spotsbuffer [1% sodium dodecyl sulfate (SDS), 25 mmol/L
ethylenediaminetetraacetic acid (EDTA), 1 mg/mL pro- between every two replicates was calculated to deter-
mine the reproducibility. The average correlation coef-teinase K, pH 8], and incubated overnight at 50C. Ribo-
nuclease A (10 mg/mL) was then added for an additional ficiency at 3, 12, and 24 hours of reperfusion was 0.81,
0.76, and 0.58, respectively, indicative of excellent repro-2-hour incubation at 37C. The chromosomal DNA was
extracted with phenol/chloroform, precipitated with eth- ducibility. We obtained and analyzed 7675 filtered genes
at 3 hours, 8061 genes at 12 hours, and 7667 genes at 24anol, and analyzed by agarose gel electrophoresis fol-
lowed by staining with ethidium bromide. hours of reperfusion, which represented 86%, 90%, and
85% of the total genes available on the chips, respec-
RNA isolation tively. Relative intensity of each spot of each channel
was determined by dividing the signal intensity of a spotWhole kidney tissues were disrupted with a Tissue
Tearor (Biospec Products). Total RNA from control and by the average signal intensity of each channel. The
paired t statistical test on log of relative intensities ofischemic kidneys was isolated using the RNeasy Mini
Kit (Qiagen, Valencia, CA, USA), verified for purity each spot between the experimental group and the con-
trol group was performed. The genes with P  0.05 andand quantitation by spectrophotometry and used for mi-
croarray experiments and RT-PCR. the median of log 2 of ratios1 or1 were considered
to be up-regulated (twofold or more) or down-regulated
Microarray procedures (twofold or more), respectively. Hierarchical clustering
analysis of the data was performed using software ob-Detailed descriptions of microarray hardware and pro-
cedures are available from http://www.aecom.yu.edu/ tained from http://rana.lbl.gov/EisenSoftware.html, as pre-
viously described [27, 30]. This software utilizes standardhome/molgen/facilities.html. Briefly, for each experi-
ment, 100 g of purified total RNA was reverse tran- statistical algorithms to generate a dendrogram that as-
sembles gene expression data into categories of similarscribed with Superscript II reverse transcriptase (Life
Technologies, Rockville, MD, USA) in the presence of patterns. Changes in expression of each individual gene
were displayed such that genes with unchanged expres-Cy3-dUTP (Amersham, Piscataway, NJ, USA) for con-
trols and Cy5-dUTP for ischemic samples. The cDNA sion are colored black, increasingly induced genes appear
red with increasing intensity, and increasingly repressedsamples were purified using a Microcon YM-50 filter
(Millipore, Madison, WI, USA), and hybridized to mi- genes appear green with increasing intensity.
croarray slides containing 8979 unique sequence-verified
Semiquantitative RT-PCRmouse probes (obtained from the Albert Einstein Col-
lege of Medicine Microarray Facility), as previously de- Equal amounts (1 g) of total RNA from control and
experimental kidneys were reverse transcribed with Su-scribed [30]. Three separate animals were examined for
each of the reflow periods, and two to four independent perscript II reverse transcriptase (Life Technologies) in
the presence of random hexamers according to the man-microarray experiments were performed for each of the
animals. The array slides were scanned using a microar- ufacturer’s instructions. PCR was accomplished using a
kit (Roche, Indianapolis, IN, USA) and mouse-specificray scanner (GenePix 4000B, Axon Instruments, Foster
City, CA, USA) to obtain separate TIFF images for Cy3 primers as follows:
FADD sense 5-CACCAGGTCAGCCACCAGATand Cy5 fluorescence. The signal intensities for Cy3 and
Cy5 were determined for individual genes using the Gene- TCAG-3
FADD antisense 5-GTGTGTGACAATGTGGGG-3Pix Pro 3.0 data extraction software (Axon Instruments).
DAXX sense 5-GCCTCTGTGGCTTCTGTCGC-3
Quality control and data analysis DAXX antisense 5-CTAATCAGAGTCTGAAAG
CACG-3Data obtained from GenePix Pro 3.0 was imported
into Microsoft Excel Macros for further statistical analy- p53 sense 5-CCACTTGATGGAGAGTATTTC-3
p53 antisense 5-GTCTGAGTCAGGCCCCAC-3sis as previously published by our group [57–59]. The
statistical significance test between spot intensity and BAD sense 5-CCCCCCAATCTCTGGGCAGCG-3
BAD antisense 5-TCACTGGGAGGGGGTGGAsurrounding background intensity was performed for
each spot of each channel. The spots with P 	 0.001 for GCC-3
BAK sense 5-GGTTTGACCGGCTTCCTGGG-3both Cy3 and Cy5 channels were considered noise and
were eliminated from further analysis. The intensity of BAK antisense 5-TCATGATCTGAAGAATCTG
TGTACC-3each filtered spot was corrected by subtracting the imme-
diate surrounding background. Global intensity normal- Mouse-specific primer pairs for
-actin and glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH) were ob-ization within the array was performed by calculating
the average log of the corrected signal intensities of the tained from Clontech (La Jolla, CA). Mock reactions de-
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Fig. 1. Hematoxylin-eosin and terminal deoxynucleotidyl transferase-mediated uridine triphosphate nick end labeling (TUNEL) stains. A hematox-
ylin-eosin stain of kidney sections from control mice (A) and after ischemia and 24 hours of reflow (B). The results of TUNEL staining of kidney
sections from control mice (C) and after ischemia and 24 hours of reflow (D). Arrows point to condensed and fragmented TUNEL-positive nuclei.
DNA laddering assay from control or ischemic kidneys harvested at various reperfusion periods as indicated (E ). Apoptotic DNA fragmentation
was evident after 12 hours of reflow. M is a 100 bp molecular weight marker.
void of cDNA served as negative controls. PCR products tional consequences of brief periods of renal ischemia
were analyzed by agarose gel electrophoresis followed have been documented [10–12]. The characteristic histo-
by staining with ethidium bromide, and quantitated by pathologic features of ischemic injury were readily evi-
densitometry. Fold changes in mRNA expression in isch- dent in the 24-hour reperfusion samples. These included
emic versus control kidneys were detected following nor- a loss of brush-border membranes, tubular dilatation,
malization for 
-actin or GAPDH amplification. flattened tubular epithelium, luminal debris, and an in-
terstitial infiltrate (Fig. 1B), as previously describedImmunohistochemistry
[10, 11]. We documented the presence of apoptotic cells
Paraffin-embedded sections were deparaffinized and
using the TUNEL assay. Apoptosis was largely confinedrehydrated through two changes of xylene and graded
to the outer medullary region, with only occasionalalcohols, fixed with 4% formaldehyde/PBS, blocked with
TUNEL-positive cells being detected in the cortex. Apo-goat serum, and incubated with primary antibodies for
ptotic nuclei were detectable in the outer medulla within1 hour at room temperature as follows: FADD (1:250,
12 hours of reperfusion (about 3% of tubular cells perTransduction Laboratories), BAK (1:1000, Upstate Bio-
100 counted) and were more abundant in the 24-hourtechnologies), BAD (1:1000, Transduction Labora-
reperfusion group (about 6% of tubular cells per 100tories), and DAXX (1:1000, Upstate Biotechnologies).
counted), as illustrated in Figure 1D. Apoptosis was pre-Slides were then exposed for 30 minutes at room temper-
ature in the dark to secondary antibodies conjugated dominantly localized to distal tubular cells and ascending
with Cy5 (Amersham). Serial sections were subjected to limb of Henle’s loop, both in detached cells within the
the TUNEL assay procedure as previously described. lumen as well as attached cells. Occasional proximal
Visualization with rhodamine filters revealed cells that tubular cells were also apoptotic, but the glomeruli were
stained positive for the specific proapoptotic antigens essentially devoid of apoptosis. No TUNEL-positive
examined, and examination with fluorescein filters iden- cells were detected in the control kidneys (Fig. 1C) or
tified TUNEL-positive nuclei in serial sections. in the ischemic samples where TdT was omitted (not
shown).
RESULTS We confirmed the presence of apoptosis using the
DNA laddering assay, which revealed the characteristicIschemia/reperfusion injury results in characteristic
morphologic changes and apoptosis of tubular 180 bp DNA fragmentation pattern in the ischemic kid-
epithelial cells neys after 12 and 24 hours of reperfusion (Fig. 1E).
Control kidneys were devoid of fragmented DNA at allWe employed a well-established murine model of isch-
emia/reperfusion injury, in which the structural and func- reperfusion periods.
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Fig. 2. Venn diagram illustrating the number of transcripts that were
consistently up-regulated (A ) or downregulated (B ) more than twofold,
at each of the reflow periods examined.
Ischemia/reperfusion injury results in consistent
patterns of altered gene expression
We employed cDNA microarrays containing approxi-
mately 9000 sequence-verified probes and stringent qual-
ity control and data analysis protocols to identify global Fig. 3. Analysis of clusters. Left panel shows the dendrogram result
of hierarchical clustering of genes at each reflow period. Changes inchanges in renal gene expression during the early reper-
expression of each individual gene (represented by a horizontal line)fusion periods following ischemic injury in a mouse
were displayed such that genes with unchanged expression are colored
model. Three separate mice were examined at each of black, increasingly induced genes appear with increasing intensity (A
to C), and increasingly repressed genes appear (D to F) with increasingthe reperfusion periods (3, 12, and 24 hours), and two
intensity. Also shown are the six major gene clusters identified (Ato four separate microarray experiments were performed
through F). The right panel shows the temporal pattern of gene expres-
for each animal examined. Statistical analysis revealed sion within each of these clusters. The x-axis shows the reflow periods
and the y-axis shows the fold change in gene expression.that within each reperfusion period, there was a high
degree of reproducibility in the gene expression patterns.
Expression patterns of several renal genes were consis-
tently altered in a duration-dependent manner following Table 1. Cluster A: Transcripts up-regulated at 12 and 24 hours
ischemia, including 91 genes that were up-regulated 2-
Growth/proliferation Signal transductionfold and 156 genes down-regulated 2-fold at all reper-
Insulin-like growth factor 1 Interleukin 6
fusion periods examined (Fig. 2). Hierarchical clustering Insulin-like growth factor-binding
protein 10 Interleukin 8revealed approximately six major patterns of temporal
Retinol-binding protein 1 Protein kinase C gammachanges in gene expression (Fig. 3 A to F). The identified
Thymopoietin CD 14
genes are tabulated in Tables 1 to 6. Cluster C (Table Repair/cytoprotection CD 68
Crystallin alpha CDC2-related kinase3) contained several genes that have previously been
Cystatin B CDC2 protein kinase 1shown to be up-regulated early followed by a rapid de-
Cytoskeleton Unclassified
cline, including transcription factors such as Egr-1 and Tubulin beta 5 Nedd 4
Tubulin alpha 4 N-CAMc-fos [31, 32], repair genes such as heat shock protein 70
(HSP-70) [33], and growth factors such as hepatocyte
growth factor (HGF) [34] and Bcl-2 [15, 16]. The identi-
fied genes that remained up-regulated at later periods
[37], and the cell cycle protein p21 [38], and cytoprotec-of reflow (clusters B and A) are shown in Table 2 and
tive factors such as heme oxygenase-1 [39] and alpha1, respectively. Several genes in clusters B and A have
crystallin [40]. Similarly, previously described genesalso been previously shown to be up-regulated at an
down-regulated during reflow periods (clusters E and F,intermediate period following the acute insult. These
Tables 5 and 6) include sodium-hydrogen exchanger 3include growth factors like heparin-binding epidermal
(NHE-3) [41], alpha-albumin [42], and members of thegrowth factor (HB-EGF) [35], insulin-like growth factor
1 (IGF-1) [36], transforming growth factor-
1 (TGF-b1) cytochrome P-450 family [42]. Thus, our results con-
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Table 2. Cluster B: Transcripts up-regulated at 3, 12, and 24 hours
Proapoptotic Growth/proliferation
FADD Platelet-derived growth factor 
DAXX HB-epidermal growth factor
P53 Cell cycle protein p21
BAD Angiopoietin
Repair/cytoprotection Metabolism
Heme oxygenase-1 Sphingosine kinase I
Excision repair-1 Lactate dehydrogenase 1
RNA polymerase II Phosphatidic acid phosphatase
Signal transduction Cytoskeleton
Transforming growth factor-
1 Claudin 7
Interleukin 2 receptor gamma Cadherin 5
Interleukin 4 receptor alpha Smoothelin
Growth factor receptor bound (Grb) 2 Palladin
Ras-like guanosine triphosphate binding protein Rad Talin
Integrin alpha3 Vinculin
Integrin beta2 Cortactin
CD151 Tropomyosin 4
Endothelial nitric oxide synthase 3 Filamin
Mean arterial pressure kinase 7 Tubulin beta2
Transport Unclassified
Prostaglandin transporter Formin
Na-dependent phosphate transporter 3 Formin binding protein 4
Vacuolar proton pump Lamin A
Hemoglobin alpha Laminin alpha 5
Potassium-chloride co-transporter KCC1 Laminin gamma 2
Unclassified Smoothelin
Metallothionein 1 Jumonji
Lymphoid enhancer binding factor 1 Lipocalin/NGAL
Testis-specific gene A12 14-3-3 protein sigma
Shroom TG interacting factor
N-ras Annexin A6
Axin Microspherule protein 1
Table 4. Cluster D: Transcripts down-regulated at 3 hours onlyTable 3. Cluster C: Transcripts up-regulated at 3 hours only
Proapoptotic Growth/proliferation Alpha actinin 3 Tenascin C
Proliferating cell nuclear antigen Procollagen type IIIBAK Hepatocyte growth factor
Anti-apoptotic Transcription factors Ubiquitin conjugating enzyme 1 Activin A receptor
Translocator of mitochondrial membrane 44 DNA-binding protein ABcl-2 c-Fos
NF-B Egr-1
Signal transduction Immediate early response gene
Janus tyrosine kinase
(JAK) 1 N-myc Ischemia/reperfusion injury results in consistent
Mean arterial pressure
up-regulation of several proapoptotic moleculeskinase 2 Unclassified
Rho B Hexokinase 1 Our microarray analysis revealed a marked up-regula-
Repair/cytoprotection Polypyrimidine tract-binding protein
tion of several proapoptotic genes in the early postische-Heat shock protein 70 Spectrin beta-3
Heat shock protein 40 PPAR-binding protein mic period. The most prominent change was noted for
FADD, which was up-regulated 2.1-fold, 5.4-fold, and
6.1-fold at 3, 12, and 24 hours of reperfusion, respectively.
Significant increases in expression were also noted at all
reflow periods for DAXX (1.9-fold, 2.5-fold, and 2.5-foldfirmed the changes in expression of a subset of genes
previously implicated in renal ischemic/reperfusion in- at 3, 12, and 24 hours of reperfusion, respectively), p53
(2.2-fold, 2.4-fold, and 2.2-fold at 3, 12, and 24 hours ofjury, thereby validating our experimental microarray
protocols. In addition, several previously unrecognized reperfusion, respectively), and BAD (2.5-fold, 3-fold,
and 2.5-fold at 3, 12, and 24 hours of reperfusion, respec-genes were consistently shown to be differentially ex-
pressed (Tables 1 to 6), and a detailed analysis of these tively). In contrast, the expression of BAK was signifi-
cantly up-regulated (3.2-fold) only at 3 hours of reflow.changes is beyond the scope of this report. Based on
the documentation of apoptotic tubule cell death in this The immediate response to ischemic injury was also char-
acterized by increased expression of the antiapoptoticmodel by others [10, 11] and by us (Fig. 1), we chose to
further examine genes that have been previously impli- genes Bcl-2 (as previously reported in reference 15) and
nuclear factor-kappa B (NF-jB) (not previously reported).cated in programmed cell death.
Supavekin et al: Gene expression following ischemia1720
Table 6. Cluster F: Transcripts down-regulated at 12 and 24 hoursTable 5. Cluster E: Transcripts down-regulated
at 3, 12, and 24 hours
Metabolism Transport
Metabolism Transport Alcohol dehydrogenase 1 Aquaporin-1
Acetyl CoA synthetase UnclassifiedGlycolate oxidase 3 Sodium-hydrogen exchanger 3
Amine N-sulfotransferase Copper transporter 1 Cytochrome P 450 4a10 Kidney androgen regulated protein
Cytochrome P 450 4a14 Myosin VaAdenylate cyclase 6 Zinc transporter 1
Acyl-CoA dehydrogenase 1 Calcium-binding protein 39 Fructose bisphosphate 1 Esterase 1
Hydroxysteroid 11-beta
dehydrogenase 1 Ferritin heavy chain
Hydroxyacid oxidase 1 Alpha albumin protein
Branched chain aminotransferase 1 Selenoprotein P1
Phosphotriesterase Signal transduction after 24 hours of reflow showed significant staining for
l-threonine 3-dehydrogenase CD19
FADD, BAK, BAD, and DAXX (Fig. 5). The stainingVery long chain acyl-CoA
synthetase CD36 was localized predominantly to distal tubule cells, and
Glycerol-3-phosphate was absent from glomeruli. In serial sections, the major-
acyltransferase Kininogen
ity of cells that stained positive for these proapoptoticCarnitine palmitoyltransferase 1 Neuropilin
Peptidylprolyl isomerase c Cell cycle factors also revealed TUNEL-positive nuclei.
Phenylalanine hydroxylase Cyclin 1
Cytochrome P 450 2j5 Cyclin D1
Cytochrome P 450 2d10 Cyclin E2 DISCUSSIONGlycerol kinase Unclassified
Pyruvate dehydrogenase Dynamin In the present study, we have utilized cDNA microar-
Stearoyl-CoA desaturase Protein 4.1 ray technology and stringent statistical analysis to defineKidney and liver proline oxidase 1 Pantophysin
global changes in renal gene expression during the earlyCytochrome c oxidase subunit Vb Alpha2 macroglobulin
Fatty acid synthase Butyrate response factor 1 reperfusion periods following ischemic injury in an estab-
Acyl-coenzyme A oxidase Peroxisomal biogenesis lished mouse model. We have shown that tubule cellfactor
apoptosis is a detectable morphologic event in thisHydroxysteroid 17-beta
dehydrogenase 1 NudeL model. We identified several transcripts that have pre-
Carnitine-acylcarnitine translocase Kruppel-like factor 9 viously been shown to be overexpressed or repressedGrowth/proliferation TIMP-3
following ischemic injury, thereby validating this tech-Insulin-like growth factor 2 Nit-2
Insulin-like growth factor-binding nique. For example, our results have confirmed previous
protein 5 Tip-30 reports documenting by alternative methods the up-reg-
ulation of genes such as Bcl-2 [15, 16], Egr-1 [31], c-Fos
[32], HSP-70 [33], HGF [34], HB-EGF [35], IGF-1 [36],
TGF-
1 [37], p21 [38], heme oxygenase 1 (HO-1) [39],The finding of up-regulated proapoptotic transcripts
and alpha crystallin [40]. Similarly, previously describedby microarray analysis was confirmed by semiquantita-
transcripts that are down-regulated following ischemiative RT-PCR, using a normalization protocol with both
that were also identified in our study include NHE3b-actin and GAPDH. No significant changes in mRNA
[41], alpha-albumin [42], and members of the cytochromeexpression of either 
-actin or GAPDH were noted at
P-450 family [42]. In addition, several previously unrec-any of the reperfusion periods examined. However, we
ognized genes were consistently shown to be differen-detected a significant up-regulation of FADD (1.3-fold,
tially expressed and a detailed analysis of these tran-3.5-fold, and 4.2-fold at 3, 12, and 24 hours of reperfusion,
scripts is beyond the scope of this report. Based on therespectively), DAXX (1.2-fold, 2.2-fold, and 3.5-fold at
documentation of apoptotic tubule cell death in this3, 12, and 24 hours of reperfusion, respectively), p53
model by others [10, 11] and by us (Fig. 1), we chose to(1.5-fold, 1.8-fold, and 2.2-fold at 3, 12, and 24 hours of
further examine genes that have been previously impli-reperfusion, respectively), BAD (1.4-fold, 3.3-fold, and
cated in programmed cell death.3.2-fold at 3, 12, and 24 hours of reperfusion, respec-
A consistent finding of the present study is the up-tively), and BAK (2.8-fold, 1.9-fold, and 1.4-fold at 3,
regulation of several proapoptotic transcripts by mi-12, and 24 hours of reperfusion, respectively). These
croarray analysis, which was confirmed by semiquantita-results are illustrated in Figure 4 and are in overall agree-
tive RT-PCR and immunohistochemistry. These genesment with the changes detected by microarray analysis.
included FADD and DAXX, members of the extrinsicThe finding of up-regulated proapoptotic transcripts
death receptor pathway. These ligands are known towas confirmed at the protein level by immunohistochem-
transduce apoptotic signals emanating from cell surfaceistry. Serial sections were examined for expression of
receptors such as Fas, with resultant activation of caspasethe identified proapoptotic proteins and by TUNEL
8 [20]. Expression of Fas has previously been docu-assay for apoptotic nuclei. Control sections were essen-
mented in renal tubule cells both in vivo [10] and in vitrotially devoid of immunoreactivity with the antibodies
examined (not shown). In contrast, sections from kidneys [8], and up-regulation of Fas protein has been shown to
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Fig. 4. Expression of proapoptotic transcripts, expressed as the fold change compared to control. The straight lines represent results obtained by
microarray analysis, and the dashed lines show the results of semiquantitative reverse transcription-polymerase chain reaction (RT-PCR). The
x-axis shows the reflow periods and the y-axis shows the fold change in gene expression.
Fig. 5. Expression of proapoptotic proteins by immunohistochemistry. Serial sections were stained for terminal deoxynucleotidyl transferase-
mediated uridine triphosphate nick end labeling (TUNEL)-positive nuclei (top panel) and primary antibodies (Pabs) to proapoptotic antigens as
shown (bottom panel). The majority of cells expressing the proapoptotic proteins examined also revealed TUNEL-positive nuclei.
occur in mouse kidney after a 24-hour reflow period Transcripts belonging to the intrinsic mitochondrial
apoptotic pathway, namely BAD and BAK, were alsofollowing ischemia [10, 43]. Similarly, renal expression
of FADD has been demonstrated in vivo [44] and in vitro consistently induced in this study. These proapoptotic
molecules of the Bcl-2 family normally reside in the[45]. Furthermore, we have previously demonstrated a
rapid up-regulation of Fas and FADD protein and activa- cytosol, but can undergo activation and mitochondrial
translocation following an apoptotic stimulus, leading totion of caspase 8 in cultured tubule cells following an in
vitro ischemic injury [8]. Collectively, our previous and release of cytochrome c and activation of caspase 9
[21, 22]. Both molecules are expressed in kidney tubulepresent studies suggest that induction of the Fas-FADD-
caspase 8 pathway may play an important pathogenetic cells [47, 48]. In the present study, BAK was found to
be transcriptionally up-regulated exclusively at the 3-hourrole in the initiation of tubule cell apoptosis during the
early reperfusion period. The precise role of DAXX in reflow period, whereas the induction of BAD was evi-
dent at all times examined. It is interesting to note thatkidney cell apoptotic cascades is unclear. However, it
is worthwhile noting that DAXX mediates both Fas- the antiapoptotic genes Bcl-2 and NF-jB were also up-
regulated at earlier time periods in our study. Bcl-2 playsdependent and TGF-
–induced apoptosis [46], and the
marked renal induction of TGF-
 following ischemia is a pivotal protective role by inhibiting mitochondrial cyto-
chrome c release [21], and our findings confirm previouswell documented by other investigators [37] and in this
study (Table 2). reports of enhanced tubule cell Bcl-2 expression follow-
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ing renal ischemia/reperfusion injury [15, 16]. NF-kB activation of the “executioner” caspase cascades and en-
donucleases, and final entry into the “postmortem” phase.comprises a family of transcription factors that regulate
A major limitation of our study pertains to the fact thatthe expression of several genes involved in inflammation,
alterations in gene expression identified by microarrayproliferation, and antiapoptosis [49]. NF-B is expressed
analysis are not necessarily predictive of downstreamin kidney tubule cells and is up-regulated following ure-
functional and/or pathophysiologic pathways. Thus, al-teral obstruction and in proteinuric states [49]. Our find-
though we have confirmed an up-regulation of selectings allow us to hypothesize that the simultaneous induc-
proapoptotic genes at the mRNA level and even at thetion of pro- and antiapoptotic transcripts may account
protein level, multiple additional posttranscriptional andfor the paucity of apoptotic cells at the 3-hour reflow
posttranslational events may be required to fully impli-period. However, the continued up-regulation of extrin-
cate these factors in the programmed cell death followingsic and intrinsic proapoptotic pathway transcripts as ob-
renal ischemia/reperfusion injury. For example, per-served in the 12- and 24-hour reperfusion periods, com-
taining to the putative proapoptotic molecules identifiedbined with a diminished induction of survival factors
in this report, phosphorylation and intracellular translo-such as Bcl-2 and NF-B, may tilt the balance in favor
cation are key events that determine the activity of p53of apoptosis.
and BAD, and the role of FADD is dependent on com-At least three potential levels of “cross-talk” exist
plex protein-protein interactions. It will be important inbetween the extrinsic and intrinsic apoptotic pathways.
future studies to fully examine the behavior of theseFirst, initial activation of caspase 8 via the Fas-FADD
factors in order to confirm their role in tubule cell deathaxis can induce the mitochondrial translocation of BID, a
following renal ischemia/reperfusion injury.proapoptotic member of the Bcl-2 family, with resultant
Another limitation of this study pertains to the animalcytochrome c release and activation of caspase 9 [50].
model. We have used a mouse model of unilateral renalSecond, the p53 gene is a potent transcription factor that
pedicle occlusion to simulate ischemic renal injury, butregulates apoptosis most notably by activating proapo-
remain cognizant of the fact that there are questionsptotic Bcl-2 family members as well as the Fas-FADD
regarding its adequacy as a paradigm for human isch-axis [23]. Up-regulation of p53 has been documented in
emia/reperfusion injury [60]. For example, first, occlu-previous studies following 24 hours of reflow [51] and
sion of the renal pedicle can produce both an ischemicin the present study at 3, 12, and 24 hours of reperfusion
injury as well as an obstructive component due to occlu-following renal ischemia, presumably as a result of cellu-
sion of the renal vein. Second, the contralateral kidney,lar hypoxia and DNA damage. Third, both pathways
which was used as a control, may undergo hemodynamicculminate in the activation of caspase 3, with subsequent
changes and responses to factors released by the oc-
entry into the “execution” phase of apoptosis [19]. Our
cluded kidney, both of which may induce alterations in
overall findings suggest induction of multiple apoptotic gene expression, as has recently been demonstrated in
pathways and lend support to previous studies demon- a rat model of renal ischemia/reperfusion injury [61].
strating the up-regulation of the final common caspase However, although this and related animal models are
3 following renal ischemia [43, 52, 53] and to the notion imperfect, they are indispensable, and their study has
of caspase inhibition as a potential therapeutic tool in yielded a wealth of critical and pertinent information
renal ischemia/reperfusion injury [5–9, 52–55]. over the years [60]. Furthermore, using our microarray
Examination of the temporal relationship between analysis and RT-PCR, a comparison of apoptotic gene
gene expression and morphologic evidence for apoptosis expression did not reveal any changes in mRNA abun-
is of interest. Whereas proapoptotic gene expression was dance for FADD, DAXX, BAD or BAK (the proapo-
induced within 3 hours of reperfusion, apoptosis was ptotic transcripts examined in this manuscript) within
detectable by DNA laddering or TUNEL assay only the contralateral (control) kidneys at 3, 12, or 24 hours
at the 12-hour (and was more evident at the 24-hour) of reperfusion in our mouse model (not shown).
reperfusion time point. The apparent delay in the ap- The response of renal tubular cells to an ischemic
pearance of apoptotic cells is attributable to the facts insult includes cell death, dedifferentiation of viable cells,
that (1) the proapoptotic genes induced belong primarily proliferation, differentiation, and restitution of a normal
to the group of factors involved in the early “stimulus epithelium [2, 3]. The molecular mechanisms underlying
recognition and transduction” phases of apoptosis; (2) each of these phenomena are under active investigation
DNA fragmentation as detected by laddering or TUNEL and hold significant promise for novel therapeutic mea-
assay are terminal events that occur in the “post-mor- sures. This multifaceted response is reflected in detail at
tem” phase of apoptosis; and (3) a significant time re- the functional genomic level in the present study, where
quirement would be anticipated for translation of signal we have screened for changes in expression of 9000 genes
recognition and transduction factors, activation of down- at various early time points following the initial insult.
We chose to examine the immediate and early responses,stream extrinsic and mitochondrial apoptotic pathways,
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induce apoptosis or necrosis of cultured mouse proximal tubularbecause (1) changes in gene expression occur soon after
cells. Am J Physiol 274:F315–F327, 1998
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